Abbott India Limited (ABBOTINDIA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Abbott India Limited (ABBOTINDIA) has a cash flow conversion efficiency ratio of 0.130x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.22 Billion ≈ $56.45 Million USD) by net assets (Rs40.11 Billion ≈ $433.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ABBOTINDIA net asset quality score to measure how much of total assets are equity-financed.
Abbott India Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Abbott India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Abbott India Limited (ABBOTINDIA) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Abbott India Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Abbott India Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ecopro BM. Co. Ltd
KQ:247540
|
0.032x |
|
Enel Chile S.A
SN:ENELCHILE
|
40.552x |
|
Gamuda Bhd
KLSE:5398
|
-0.031x |
|
Hundsun Technologies Inc
SHG:600570
|
0.024x |
|
Karman Holdings Inc.
NYSE:KRMN
|
0.001x |
|
Engie Brasil Energia S.A
F:7TE1
|
0.086x |
|
Life Time Group Holdings Inc
NYSE:LTH
|
0.084x |
|
New China Life Insurance Company Ltd
F:NCL
|
0.221x |
Annual Cash Flow Conversion Efficiency for Abbott India Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Abbott India Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Abbott India Limited (ABBOTINDIA) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs42.33 Billion ≈ $457.80 Million |
Rs10.12 Billion ≈ $109.43 Million |
0.239x | -27.10% |
| 2024-03-31 | Rs36.99 Billion ≈ $400.02 Million |
Rs12.13 Billion ≈ $131.16 Million |
0.328x | +17.02% |
| 2023-03-31 | Rs31.89 Billion ≈ $344.83 Million |
Rs8.93 Billion ≈ $96.62 Million |
0.280x | -16.63% |
| 2022-03-31 | Rs28.20 Billion ≈ $304.95 Million |
Rs9.48 Billion ≈ $102.49 Million |
0.336x | +20.33% |
| 2021-03-31 | Rs26.02 Billion ≈ $281.41 Million |
Rs7.27 Billion ≈ $78.59 Million |
0.279x | +8.47% |
| 2020-03-31 | Rs24.32 Billion ≈ $262.98 Million |
Rs6.26 Billion ≈ $67.71 Million |
0.257x | +3.61% |
| 2019-03-31 | Rs20.09 Billion ≈ $217.22 Million |
Rs4.99 Billion ≈ $53.98 Million |
0.248x | +175.47% |
| 2018-03-31 | Rs16.93 Billion ≈ $183.07 Million |
Rs1.53 Billion ≈ $16.51 Million |
0.090x | -59.27% |
| 2017-03-31 | Rs13.87 Billion ≈ $149.99 Million |
Rs3.07 Billion ≈ $33.22 Million |
0.222x | +6.50% |
| 2016-03-31 | Rs11.96 Billion ≈ $129.30 Million |
Rs2.49 Billion ≈ $26.89 Million |
0.208x | -9.21% |
| 2015-03-31 | Rs9.38 Billion ≈ $101.39 Million |
Rs2.15 Billion ≈ $23.23 Million |
0.229x | +53.60% |
| 2014-03-31 | Rs8.33 Billion ≈ $90.09 Million |
Rs1.24 Billion ≈ $13.44 Million |
0.149x | -4.81% |
| 2013-03-31 | Rs6.47 Billion ≈ $69.96 Million |
Rs1.01 Billion ≈ $10.96 Million |
0.157x | +254.26% |
| 2012-03-31 | Rs5.44 Billion ≈ $58.85 Million |
Rs240.66 Million ≈ $2.60 Million |
0.044x | -70.68% |
| 2011-03-31 | Rs3.05 Billion ≈ $33.03 Million |
Rs460.64 Million ≈ $4.98 Million |
0.151x | +10.24% |
| 2010-03-31 | Rs2.72 Billion ≈ $29.37 Million |
Rs371.57 Million ≈ $4.02 Million |
0.137x | -65.29% |
| 2009-03-31 | Rs2.21 Billion ≈ $23.93 Million |
Rs872.13 Million ≈ $9.43 Million |
0.394x | +196.26% |
| 2008-03-31 | Rs2.31 Billion ≈ $24.98 Million |
Rs307.40 Million ≈ $3.32 Million |
0.133x | -19.72% |
| 2007-03-31 | Rs2.46 Billion ≈ $26.58 Million |
Rs407.40 Million ≈ $4.41 Million |
0.166x | -2.57% |
| 2006-03-31 | Rs2.16 Billion ≈ $23.41 Million |
Rs368.20 Million ≈ $3.98 Million |
0.170x | -53.15% |
| 2005-03-31 | Rs1.88 Billion ≈ $20.36 Million |
Rs683.70 Million ≈ $7.39 Million |
0.363x | -- |
About Abbott India Limited
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, … Read more